C. Kempf

444 total citations
21 papers, 318 citations indexed

About

C. Kempf is a scholar working on Infectious Diseases, Neurology and Oncology. According to data from OpenAlex, C. Kempf has authored 21 papers receiving a total of 318 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Infectious Diseases, 5 papers in Neurology and 5 papers in Oncology. Recurrent topics in C. Kempf's work include COVID-19 Clinical Research Studies (6 papers), Long-Term Effects of COVID-19 (5 papers) and COVID-19 and healthcare impacts (4 papers). C. Kempf is often cited by papers focused on COVID-19 Clinical Research Studies (6 papers), Long-Term Effects of COVID-19 (5 papers) and COVID-19 and healthcare impacts (4 papers). C. Kempf collaborates with scholars based in France, United States and United Kingdom. C. Kempf's co-authors include J. Kempf, David T. Rubin, Javaria Mona Khalid, Jean‐Frédéric Colombel, William J. Sandborn, Brian G. Feagan, Fatima Bhayat, Stéphane Haÿs, Estelle Jumas‐Bilak and Olivier Claris and has published in prestigious journals such as SHILAP Revista de lepidopterología, Clinical Nutrition and Journal of Pediatric Gastroenterology and Nutrition.

In The Last Decade

C. Kempf

20 papers receiving 311 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
C. Kempf France 9 96 72 60 49 46 21 318
Abdülmecit Yıldız Türkiye 11 26 0.3× 70 1.0× 48 0.8× 57 1.2× 72 1.6× 69 339
Shon Meek United States 10 19 0.2× 114 1.6× 46 0.8× 147 3.0× 35 0.8× 21 422
Gwenn E. McLaughlin United States 11 58 0.6× 92 1.3× 42 0.7× 100 2.0× 74 1.6× 29 392
Fares Chedid United Arab Emirates 11 17 0.2× 63 0.9× 35 0.6× 78 1.6× 24 0.5× 37 328
Urban Myrdal Sweden 12 77 0.8× 120 1.7× 92 1.5× 144 2.9× 89 1.9× 16 420
Iraj Shahramian Iran 10 30 0.3× 111 1.5× 25 0.4× 112 2.3× 37 0.8× 100 350
Talkad S. Raghuveer United States 11 157 1.6× 60 0.8× 62 1.0× 86 1.8× 65 1.4× 28 621
Ruth McManus Canada 10 77 0.8× 99 1.4× 85 1.4× 185 3.8× 33 0.7× 22 648
Elen Almeida Romão Brazil 10 16 0.2× 44 0.6× 48 0.8× 37 0.8× 53 1.2× 38 325
Hyun Jin Kim South Korea 11 20 0.2× 144 2.0× 109 1.8× 97 2.0× 44 1.0× 42 367

Countries citing papers authored by C. Kempf

Since Specialization
Citations

This map shows the geographic impact of C. Kempf's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C. Kempf with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C. Kempf more than expected).

Fields of papers citing papers by C. Kempf

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by C. Kempf. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C. Kempf. The network helps show where C. Kempf may publish in the future.

Co-authorship network of co-authors of C. Kempf

This figure shows the co-authorship network connecting the top 25 collaborators of C. Kempf. A scholar is included among the top collaborators of C. Kempf based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with C. Kempf. C. Kempf is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Martinot, M., et al.. (2023). Clinical features and outcomes in adults with COVID-19 during the pre-Omicron and Omicron waves. Infectious Diseases Now. 54(2). 104833–104833. 2 indexed citations
3.
Diaw, Papa Alassane, et al.. (2021). Demographics and outcomes of laboratory-confirmed COVID-19 cases during the first epidemic wave in Senegal. Infectious Diseases Now. 52(1). 44–46. 1 indexed citations
4.
Kempf, C., et al.. (2021). Multifocal and Microvascular Involvement in Ischemic Stroke During COVID-19: A Cohort Study With Comparison With Non-COVID-19 Stroke. Frontiers in Neurology. 12. 732194–732194. 6 indexed citations
5.
Martinot, M., Simon Gravier, Ion Codreanu, et al.. (2021). Predictors of mortality, ICU hospitalization, and extrapulmonary complications in COVID-19 patients. Infectious Diseases Now. 51(6). 518–525. 28 indexed citations
6.
Martinot, M., et al.. (2021). Evolution of baseline characteristics and severe outcomes in COVID-19 inpatients during the first and second waves in Northeastern France. Infectious Diseases Now. 52(1). 35–39. 6 indexed citations
7.
Martinot, M., et al.. (2020). Facteur de risque d’évolution défavorable et manifestations extra-pulmonaires au cours du COVID-19. Médecine et Maladies Infectieuses. 50(6). S81–S81. 1 indexed citations
8.
Feagan, Brian G., William J. Sandborn, Jean‐Frédéric Colombel, et al.. (2018). Incidence of Arthritis/Arthralgia in Inflammatory Bowel Disease with Long-term Vedolizumab Treatment: Post Hoc Analyses of the GEMINI Trials. Journal of Crohn s and Colitis. 13(1). 50–57. 53 indexed citations
9.
Allez, Matthieu, et al.. (2018). P727 Efficacy of vedolizumab (VDZ) by disease localisation in Crohn’s disease. Journal of Crohn s and Colitis. 12(supplement_1). S479–S479. 1 indexed citations
10.
11.
Haÿs, Stéphane, Aurélien Jacquot, Hélène Gauthier, et al.. (2015). Probiotics and growth in preterm infants: A randomized controlled trial, PREMAPRO study. Clinical Nutrition. 35(4). 802–811. 63 indexed citations
12.
Mansoor, George A., et al.. (2015). Clinical attributes, treatment, and control in hypertension (CATCH)—a French and Italian longitudinal patient database study. Clinical Hypertension. 21(1). 18–18. 3 indexed citations
13.
Valensi, Paul, et al.. (2015). Treatment maintenance duration of dual therapy with metformin and sitagliptin in type 2 diabetes: The ODYSSEE observational study. Diabetes & Metabolism. 41(3). 231–238. 25 indexed citations
14.
Kempf, C., et al.. (2013). Validation of the French Translated Version of the Osteoporosis Specific Morisky Medication Adherence Scale (OS-MMAS) in France. Value in Health. 16(7). A568–A568. 1 indexed citations
15.
Bocquet, A., et al.. (2013). Effect of Infant and Follow‐on Formulas Containing B lactis and Galacto‐ and Fructo‐oligosaccharides on Infection in Healthy Term Infants. Journal of Pediatric Gastroenterology and Nutrition. 57(2). 180–187. 14 indexed citations
16.
Huguet, Marina, et al.. (2012). PCV109 Antithrombotic Therapy Prescription and Persistence in Patients With Atrial Fibrillation in France and Spain. Value in Health. 15(7). A382–A382. 1 indexed citations
17.
Turck, Dominique, et al.. (2006). Adequacy and Safety of an Infant Formula With a Protein/Energy Ratio of 1.8 g/100 kcal and Enhanced Protein Efficiency for Term Infants During the First 4 Months of Life. Journal of Pediatric Gastroenterology and Nutrition. 43(3). 364–371. 36 indexed citations
18.
Steg, Philippe Gabríel, Gilles Grollier, Marie‐Claude Morice, et al.. (2001). A randomized double-blind trial of intravenous trimetazidine as adjunctive therapy to primary angioplasty for acute myocardial infarction. International Journal of Cardiology. 77(2-3). 263–273. 45 indexed citations
19.
Kempf, C., M. Schmitt, Jean-Marc Danse, & J. Kempf. (1984). Correlation of DNA repair synthesis with ageing in mice, evidenced by quantitative authoradiography. Mechanisms of Ageing and Development. 26(2-3). 183–194. 14 indexed citations
20.
Kempf, J. & C. Kempf. (1982). Autoradiographic grain counting by fully automated image analysis.. PubMed. 86(3). 215–23. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Abdülmecit Yıldız Breakdown of academic impact, for papers by Shon Meek Breakdown of academic impact, for papers by Gwenn E. McLaughlin Breakdown of academic impact, for papers by Fares Chedid Breakdown of academic impact, for papers by Urban Myrdal Breakdown of academic impact, for papers by Iraj Shahramian Breakdown of academic impact, for papers by Talkad S. Raghuveer Breakdown of academic impact, for papers by Ruth McManus Breakdown of academic impact, for papers by Elen Almeida Romão Breakdown of academic impact, for papers by Hyun Jin Kim
Rankless by CCL
2026